Sagga, Baby Girl .

HRN: 26-09-47  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/28/2024
AMPICILLIN 500MG (VIAL)
10/28/2024
11/03/2024
IV
280mg
Q6
Pcap C
Waiting Final Action 
10/28/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
10/28/2024
11/03/2024
IVT
82mg
Q24
Pneumonia
Waiting Final Action 
10/29/2024
CEFUROXIME 750MG (VIAL)
10/29/2024
11/04/2024
IV
190mg
Q8h
PCAP C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: